Scythian Biosciences Corp (SCYB.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2019 | 09-2018 | 09-2017 | 09-2016 | 09-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 212 | 2,296 | 477 | 5 | 101 |
| Receivables | 164 | 499 | 116 | 29 | 331 |
| TOTAL | $390 | $3,005 | $602 | $36 | $559 |
| Non-Current Assets | |||||
| PPE Net | 607 | N/A | N/A | N/A | N/A |
| Investments And Advances | 1,140 | N/A | N/A | N/A | 70 |
| Intangibles | 320 | 4,239 | 1,550 | 2,204 | 2,857 |
| Other Non-Current Assets | 73 | 71 | 130 | 320 | 0 |
| TOTAL | $2,140 | $4,310 | $1,681 | $2,524 | $2,927 |
| Total Assets | $2,531 | $7,315 | $2,283 | $2,561 | $3,486 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | N/A | N/A | 177 | 215 | 153 |
| TOTAL | $663 | $543 | $177 | $423 | $162 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 29 |
| TOTAL | $458 | $0 | $0 | $0 | $29 |
| Total Liabilities | $1,122 | $543 | $177 | $423 | $191 |
| Shareholders' Equity | |||||
| Common Shares | 18,652 | 16,893 | 8,369 | 6,487 | 0 |
| Retained earnings | -25,853 | -17,832 | -9,728 | -5,848 | -3,745 |
| Other shareholders' equity | 3,206 | 2,640 | 1,614 | 973 | 477 |
| TOTAL | $1,409 | $6,772 | $2,105 | $2,138 | $3,295 |
| Total Liabilities And Equity | $2,531 | $7,315 | $2,283 | $2,561 | $3,486 |